Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 April 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Long-term benefit with photodynamic therapy for Barrett's cancer

This month's Gastrointestinal Endoscopy reports excellent long-term results of photodynamic therapy with 5-aminolevulinic acid for high-grade intraepithelial neoplasia or mucosal cancer, offering it as an alternative to surgical esophagectomy and endoscopic resection.

News image

fiogf49gjkf04

Photodynamic therapy with 5-aminolevulinic acid has proven to be safe and effective in patients with early neoplasia in Barrett's esophagus.

However, long-term results in patients with high-grade intraepithelial neoplasia or with early cancer are still lacking.

Dr Oliver Pech and colleagues from Germany evaluated the efficacy of photodynamic therapy with 5-aminolevulinic acid.

The researchers analyzed the effect of this treatment on the survival of 66 patients with early Barrett's neoplasia.

The team applied 5-aminolevulinic acid orally calculated at 60 mg per kg body weight 4 to 6 hours before photodynamic therapy.

Protoporphyrin IX induced by oral administration of 5-aminolevulinic acid was used as the photosensitizer.

Disease-free survival in patients with high-grade intraepithelial neoplasia was 89%
Gastrointestinal Endoscopy

The research team maintained acid suppression in all patients.

The researchers reported that between 1996 and 2002, 667 patients with early neoplasia in Barrett's esophagus were referred for local endoscopic therapy.

The team noted that a total of 558 patients fulfilled the criteria for local endoscopic therapy.

However, only 66 patients with a mean age of 61 years were treated by photodynamic therapy.

The patients were separated into 2 groups, with 35 with high-grade intraepithelial neoplasia in Group 1 and 31 patients with early adenocarcinoma in Group 2.

The researchers reported that a total of 82 photodynamic therapies with 5-aminolevulinic acid were performed.

The team found that 34 of the 35 patients in Group 1 and all patients in group 2 achieved a complete response during a median follow-up period of 37 months.

The researchers observed 1 local recurrence in Group 1 and 10 in group 2.

The team noted that 7 patients died during follow-up, but that all deaths were not tumor related.

No major complications were observed.

The team noted that disease-free survival in patients with high-grade intraepithelial neoplasia was 89%, and, in for mucosal cancer, it was 68%.

The calculated 5-year survival was 97% in Group 1 and 80% in Group 2, but there occurred no death related to Barrett's neoplasia.

Dr Pech's team concluded, “This study shows excellent long-term results of photodynamic therapy with 5-aminolevulinic acid in patients with high-grade intraepithelial neoplasia or mucosal cancer.”

Photodynamic therapy with 5-aminolevulinic acid might be offered as an alternative to surgical esophagectomy and endoscopic resection, especially in cases with multifocal Barrett's neoplasia.”

Gastrointest Endosc 2005: 62(1): 24
18 July 2005

Go to top of page Email this page Email this page to a colleague

 20 April 2018 
Obesity and physical activity in diverticulosis
 20 April 2018 
Worldwide H.pylori prevalence
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 20 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 19 April 2018 
Fibrosis in patients with chronic hepatitis B
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA
 18 April 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 18 April 2018 
Hep C treatment for sustained virologic response
 18 April 2018 
Endoscopic necrosectomy reduces risk of death 
 17 April 2018 
Colorectal cancer screening and ethnic inequities
 17 April 2018 
Training programs should consider radiation education for advanced endoscopy fellows
 17 April 2018 
Aspirin and pancreatic cancer
 16 April 2018 
Surgery for colorectal polyps has increased 
 16 April 2018 
Advanced fibrosis can be ruled out in primary health care patients
 16 April 2018 
Antibiotic use and colorectal adenoma
 13 April 2018 
Colorectal cancer cell lines
 13 April 2018 
Infliximab and corticosteroid-free clinical remission in Crohn's
 13 April 2018 
Teduglutide for children with short bowel syndrome
 12 April 2018 
Prescriptions for opiate drugs amongst primary care patients with IBD
 12 April 2018 
Lower GI bleeding related to comorbidity
 12 April 2018 
non–Clostridium difficile bacterial infections in IBD
 11 April 2018 
Physician perception of IBD trial results
 11 April 2018 
Bile acid deficiency in IBS 
 11 April 2018 
Stem cell therapy for fistulas in Crohn's
 10 April 2018 
Overweight in childhood and type 2 diabetes
 10 April 2018 
immunoglobulin G associates with clinical features of IBD
 10 April 2018 
T-cells repertoires in celiac disease
 09 April 2018 
Biomarker tests for colorectal cancer screening
 09 April 2018 
Fecal transplantation in C. difficile infection and treatment outcome 
 09 April 2018 
No weigh-loss drug improved all cardiometabolic risk factors
 06 April 2018 
Colonoscopy and colorectal cancer mortality
 06 April 2018 
Eosinophilic esophagitis and health-related quality of life
 06 April 2018 
Microbiome in athletes vs sedentary subjects
 05 April 2018 
Laparoscopic Nissen fundoplication for GERD treatment
 05 April 2018 
Random biopsies for neoplasia in IBD
 05 April 2018 
Scoring system identifies cancer risk in Barrett's
 04 April 2018 
Alpha‐1 antitrypsin deficiency and liver disease
 04 April 2018 
PPI and risk of stroke
 04 April 2018 
Adjuvant chemotherapy for advanced colon cancer
 29 March 2018 
Prevention of metachronous gastric cancer
 29 March 2018 
Acute lower GI bleeding
 28 March 2018 
Decision aid used by IBD patients
 28 March 2018 
Transition for young adults with IBD
 28 March 2018 
Amitriptyline in functional dyspepsia
 27 March 2018 
Emergency department utilization for IBD 
 27 March 2018 
Management of hemorrhoids in the USA
 27 March 2018 
Adult ulcerative colitis
 26 March 2018 
Biological therapy response in IBD 
 26 March 2018 
Obesity and diverticulosis
 26 March 2018 
Practice guidelines for chronic constipation
 23 March 2018 
Health-related quality of life in eosinophilic esophagitis
 23 March 2018 
Genetics and chronic liver disease
 23 March 2018 
Global prevalence of H.pylori
 22 March 2018 
H. pyloris and gastric cancer
 22 March 2018 
Pancreatitis after IBS treatment 
 22 March 2018 
Mechanisms of action in patients with IBS
 21 March 2018 
Panel markers for early detection of colon cancer

 21 March 2018 
Blood test differentiates celiac disease
 21 March 2018 
Patient characteristics and colonoscopy preparation

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us